Folgen
Michael A. Durante, MD, PhD
Michael A. Durante, MD, PhD
Bestätigte E-Mail-Adresse bei med.miami.edu
Titel
Zitiert von
Zitiert von
Jahr
Single-cell analysis reveals new evolutionary complexity in uveal melanoma
MA Durante, DA Rodriguez, S Kurtenbach, JN Kuznetsov, MI Sanchez, ...
Nature communications 11 (1), 1-10, 2020
3032020
Single-cell analysis of olfactory neurogenesis and differentiation in adult humans
MA Durante, S Kurtenbach, ZB Sargi, JW Harbour, R Choi, S Kurtenbach, ...
Nature neuroscience 23 (3), 323-326, 2020
1952020
Punctuated evolution of canonical genomic aberrations in uveal melanoma
MG Field, MA Durante, H Anbunathan, LZ Cai, CL Decatur, AM Bowcock, ...
Nature communications 9 (1), 116, 2018
1642018
Gain of function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies
H Yang, S Kurtenbach, Y Guo, I Lohse, MA Durante, J Li, Z Li, H Al-Ali, ...
Blood 131 (3), 328-341, 2018
1542018
Gain-of-function of ASXL1 truncating protein in the pathogenesis of myeloid malignancies
H Yang, S Kurtenbach, Y Guo, I Lohse, M Durante, P Zhang, Y Zhou, ...
Blood 130 (Supplement 1), 564-564, 2017
1542017
Cytoplasmic p27 promotes epithelial–mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation
D Zhao, AH Besser, SA Wander, J Sun, W Zhou, B Wang, T Ince, ...
Oncogene 34 (43), 5447-5459, 2015
1392015
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas
MG Field, MA Durante, CL Decatur, B Tarlan, KM Oelschlager, JF Stone, ...
Oncotarget 7 (37), 59209, 2016
1252016
Drug and disease signature integration identifies synergistic combinations in glioblastoma
V Stathias, AM Jermakowicz, ME Maloof, M Forlin, W Walters, RK Suter, ...
Nature Communications 9 (1), 5315, 2018
942018
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma
F Faião-Flores, MF Emmons, MA Durante, F Kinose, B Saha, B Fang, ...
Clinical Cancer Research, clincanres. 3382.2018, 2019
812019
BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers
JN Kuznetsov, TH Aguero, DA Owens, S Kurtenbach, MG Field, ...
Science advances 5 (9), eaax1738, 2019
652019
2016
H Field, MA Durante, CL Decatur, B Tarlan, KM Oelschlager, JF Stone
Science without Numbers, 1980
441980
Mechanisms of antigen escape from BCMA-or GPRC5D-targeted immunotherapies in multiple myeloma
H Lee, S Ahn, R Maity, N Leblay, B Ziccheddu, M Truger, M Chojnacka, ...
Nature Medicine 29 (9), 2295-2306, 2023
412023
Conversion strategy using an expanded genetic alphabet to assay nucleic acids
Z Yang, M Durante, LG Glushakova, N Sharma, NA Leal, KM Bradley, ...
Analytical chemistry 85 (9), 4705-4712, 2013
402013
UPhyloplot2: Visualizing Phylogenetic Trees from Single-Cell RNA-seq Data
S Kurtenbach, DA Rodriguez, MA Durante, JW Harbour
bioRxiv, 2020
182020
A novel cardiomyogenic role for Isl1+ neural crest cells in the inflow tract
KE Hatzistergos, MA Durante, K Valasaki, ACBA Wanschel, JW Harbour, ...
Science advances 6 (49), eaba9950, 2020
142020
Genomic evolution of uveal melanoma arising in ocular melanocytosis
MA Durante, MG Field, MI Sanchez, KR Covington, CL Decatur, ...
Molecular Case Studies, mcs. a004051, 2019
122019
Multiregional genetic evolution of metastatic uveal melanoma
DA Rodriguez, J Yang, MA Durante, AN Shoushtari, SJ Moschos, ...
Npj genomic medicine 6 (1), 70, 2021
82021
RB1 loss triggers dependence on ESRRG in retinoblastoma
MG Field, JN Kuznetsoff, MG Zhang, JJ Dollar, MA Durante, Y Sayegh, ...
Science advances 8 (33), eabm8466, 2022
72022
Intraocular Metastasis in Unilateral Multifocal Uveal Melanoma Without Melanocytosis or Germline BAP1 Mutations
MA Durante, SD Walter, M Paez-Escamilla, J Tokarev, CL Decatur, ...
JAMA ophthalmology, 2019
52019
HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma
SN Sriramareddy, F Faião-Flores, MF Emmons, B Saha, S Chellappan, ...
Cancer gene therapy 29 (12), 1840-1846, 2022
42022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20